Eli Lilly and Company: Diabetes Mellitus, Type 1 trials
The registry lists 75 Diabetes Mellitus, Type 1 studies with Eli Lilly and Company as lead sponsor. 4 are open to participants now and 49 have results posted.
Phase 1 33Phase 2 8Phase 3 25Phase 4 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityRecruitingNCT07803744Phase 1
- A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)RecruitingNCT07222332Phase 3
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsRecruitingNCT07222137Phase 3
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRecruitingNCT06945406Phase 1
- A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCompletedNCT05893797Not applicableResults posted
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyCompletedNCT05463744Phase 3Results posted
- A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCompletedNCT05262387Phase 1Results posted
- A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes MellitusCompletedNCT05067270Phase 1Results posted
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCompletedNCT04992312Phase 1Results posted
- A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCompletedNCT04585776Phase 2Results posted
- A Study of LY3209590 in Participants With Type 1 DiabetesCompletedNCT04450407Phase 2Results posted
- A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin PumpsCompletedNCT04276207Phase 1Results posted
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedNCT03952130Phase 3Results posted
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyCompletedNCT03830281Phase 3Results posted
- A Study of LY900014 in a Medtronic PumpCompletedNCT03760640Phase 2Results posted
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesCompletedNCT03740919Phase 3Results posted
- A Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03465878Phase 1Results posted
- A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedNCT03449433Phase 1Results posted
- A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 DiabetesCompletedNCT03433677Phase 3Results posted
- A Study of LY900014 in Japanese Participants With Type 1 Diabetes MellitusCompletedNCT03407118Phase 1Results posted
- Assessment of Mealtime Bolus Insulin BehaviorCompletedNCT03368807Results posted
- A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes MellitusCompletedNCT03341299Phase 1Results posted
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusCompletedNCT03338023Phase 3Results posted
- A Study of LY900014 in Participants With Type 1 DiabetesCompletedNCT03214367Phase 3Results posted
- A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes MellitusCompletedNCT03166124Phase 1Results posted
- A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin PumpCompletedNCT03056456Phase 1Results posted
- A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
- A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyCompletedNCT02703350Phase 1Results posted
- A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsCompletedNCT02703324Phase 1Results posted
- A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCompletedNCT02152384Phase 1Results posted
- A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCompletedNCT02109029Phase 1Results posted
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
- A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 DiabeticsCompletedNCT01925989Phase 1Results posted
- A Study of LY2605541 in Participants With Type 1 Diabetes MellitusCompletedNCT01792284Phase 3Results posted
- A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 DiabetesCompletedNCT01784211Phase 1Results posted
- A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesCompletedNCT01771250Phase 1Results posted
- A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesCompletedNCT01769404Phase 1Results posted
- A Study of LY2605541 Versus Insulin Glargine on Blood SugarCompletedNCT01654380Phase 1Results posted
- Study of LY2409021 in Participants With Type 1 DiabetesCompletedNCT01640834Phase 1Results posted
- A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCompletedNCT01600950Phase 1Results posted
- A Study in Participants With Type 1 Diabetes MellitusCompletedNCT01481779Phase 3Results posted
- A Study in Participants With Type I Diabetes MellitusCompletedNCT01454284Phase 3Results posted
- A Study in Adults With Type 1 DiabetesCompletedNCT01421147Phase 3Results posted
- Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01134107Phase 3Results posted
- A Study in Participants With Diabetic Kidney DiseaseTerminatedNCT01113801Phase 2Results posted
- Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01109316Phase 3Results posted
- A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
- A Study on the Effect of 2 Pen Devices on HbA1cCompletedNCT00985712Phase 4Results posted
- Comparison of Two Basal Insulin Therapies for Patients With Type 1 DiabetesCompletedNCT00487240Phase 3Results posted
- A Study for Patients With Diabetes Mellitus (IOPA)CompletedNCT00420095Phase 4Results posted
- A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightActive, not recruitingNCT06962280Phase 3
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or OverweightActive, not recruitingNCT06914895Phase 3
- A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT06280703Phase 1
- A Study of LY3532226 in Participants With Type 1 Diabetes MellitusCompletedNCT05887999Phase 1
- A Study of Glucose Control in Participants With Type 1 and Type 2 DiabetesWithdrawnNCT04667182
- A Study of an Insulin Management System in Participants With Type 1 or Type 2 DiabetesCompletedNCT04484779Not applicable
- A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes MellitusCompletedNCT04161976Phase 1
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 DiabetesCompletedNCT03890003Not applicable
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes MellitusCompletedNCT03849612Not applicable
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal ChallengesCompletedNCT03848767Not applicable
- A Study of Technology to Improve Glucose Control in Participants With Type 1 DiabetesCompletedNCT03758430
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)CompletedNCT03743285Not applicable
- A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT03367390Phase 1
- A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsWithdrawnNCT02623478Phase 1
- A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyWithdrawnNCT02623452Phase 1
- A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedNCT01515384Phase 1
- A Study for Patients With Type 1 Diabetes MellitusCompletedNCT00447213Phase 2/3
- Evaluate the Efficacy of Insulin Patients With Type 1 DiabetesCompletedNCT00356109Phase 3
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesCompletedNCT00127634Phase 3
- Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.CompletedNCT00063128Phase 2
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3